RET and multiple endocrine neoplasia type 2: Approximately 25% of MTCs occur in a hereditary form as multiple endocrine neoplasia type 2 A (MEN2A), MEN2B or familial MTC (FMTC, a variant of MEN2A), virtually all of which are caused by germline mutations in the RET proto-oncogene.